Sicras-Mainar, A.
Sánchez-Álvarez, L.
Navarro-Artieda, R.
Darbà, J.
Funding for this research was provided by:
Pfizer S.L.U.
Article History
Received: 20 July 2018
Accepted: 16 November 2018
First Online: 6 December 2018
Ethics approval and consent to participate
: The authors state that the manuscript is based in an investigation classified by the Spanish Agency for Medicines and Medical Devices (AEMPS) as a Post-Authorisation Study - Other Design (EPA-OD), and subsequently was approved by the Institutional Research Board of the Universitat Internacional de Catalunya in Barcelona (Code: ANT-HIP-2017-01) on September, 7th, 2017. Patient consent was not obtained as Spanish legislation excludes existing data that are aggregated for analysis and personal data are stripped of identifying details as specified in Spanish Law 15/1999, of 13 December, on Personal Data Protection.
: Not applicable.
: Antoni Sicras-Mainar is an employee of ClinicResearch. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.